Table 1.
Frequency of NK cell populations and HLA KIR ligand status in healthy study subjects
| Subject no. | Percentages of Single-Positive NK cell subsets (%)
|
HLA KIR Ligands
|
||||||
|---|---|---|---|---|---|---|---|---|
| KIR2DL2/L3 | KIR2DL1 | KIR3DL1 | KIR3DL2 | KIR− | HLA-B | HLA-C | HLA-A | |
| 1 | 3.23 | 2.82 | 1.97 | 3.06 | 8.22 | Bw4/Bw6 | C2C2 | 24,32 |
| 2 | 6.56 | 5.30 | 5.80 | 2.98 | 18.20 | Bw4/Bw6 | C1C1 | 03,26 |
| 3 | 5.52 | 0.41 | 0.78 | 1.52 | 2.78 | Bw6/Bw6 | C1C1 | 02,02 |
| 4 | 7.56 | 5.06 | 1.06 | 3.69 | 11.40 | Bw4/Bw6 | C2C2 | 03,26 |
| 5 | 22.4 | 4.78 | 0.00 | 2.75 | 17.30 | Bw6/Bw6 | C1C1 | 02,24 |
| 6 | 6.85 | 1.48 | 0.71 | 1.89 | 5.49 | Bw4/Bw6 | C1C2 | 02,11 |
| 7 | 9.45 | 1.43 | 0.97 | 3.27 | 6.13 | Bw4/Bw6 | C1C1 | 03,29 |
| 8 | 4.97 | 2.91 | 1.96 | 7.10 | 11.20 | Bw6/Bw6 | C1C1 | 02,24 |
| 9 | 4.41 | 1.81 | 3.85 | 1.37 | 12.70 | Bw4/Bw6 | C2C2 | 02,30 |
| 10 | 9.17 | 6.70 | 2.58 | 1.61 | 14.40 | Bw6/Bw6 | C1C1 | 02,11 |
| 11 | 2.32 | 1.24 | 1.54 | 0.44 | 2.30 | Bw6/Bw6 | C1C2 | 11,31 |
| 12 | 3.00 | 1.21 | 2.58 | 2.74 | 7.54 | Bw4/Bw6 | C1C2 | 02,31 |
| 13 | 5.78 | 9.56 | 0.00 | 4.11 | 16.70 | Bw4/Bw6 | C1C2 | 03,30 |
| 14 | 3.76 | 4.81 | 0.00 | 1.88 | 4.94 | Bw4/Bw6 | C1C2 | 02,68 |
| 15 | 8.01 | 1.23 | 1.02 | 1.09 | 5.17 | Bw4/Bw6 | C1C2 | 02,11 |
| 16 | 1.77 | 1.45 | 0.62 | 1.22 | 3.57 | Bw4/Bw4 | C1C2 | 01,02 |
| 17 | 9.51 | 5.20 | 5.61 | 1.53 | 16.80 | Bw4/Bw6 | C1C1 | 03,26 |
| 18 | 8.24 | 1.01 | 4.09 | 3.05 | 10.10 | Bw4/Bw6 | C1C1 | 03,24 |
| 19 | 5.12 | 2.01 | 1.44 | 3.61 | 9.35 | Bw4/Bw6 | C1C1 | 02,24 |
KIR ligands are assigned based on HLA class I genotyping.
NK cell subsets are NKG2A−.